{"id":110774,"date":"2021-03-29T15:56:25","date_gmt":"2021-03-29T15:56:25","guid":{"rendered":"https:\/\/fin2me.com\/?p=110774"},"modified":"2021-03-29T15:56:25","modified_gmt":"2021-03-29T15:56:25","slug":"south-african-health-insurer-discovery-in-touch-with-vaccine-makers","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/","title":{"rendered":"South African health insurer Discovery in touch with vaccine makers"},"content":{"rendered":"

JOHANNESBURG (Reuters) – South African health insurer Discovery Ltd said on Monday it was in contact with all COVID-19 vaccine producers but cannot independently source vaccines as procurement and distribution is in the hands of the government.<\/p>

FILE PHOTO: The logo of South Africa’s Discovery group in seen on its headquarters in Sandton, Johannesburg, South Africa, February 20, 2020. REUTERS\/Mike Hutchings<\/figcaption>

As in many countries, vaccine procurement in South Africa is centralised and controlled by government but the pace of procurement and inoculation has been slow, with less than 250,000 people, or just 0.5% of the population vaccinated so far.<\/p>\n

This has prompted calls from health experts to allow the private sector to source vaccines to bolster government efforts.<\/p>\n

\u201cWhile we (Discovery) might be in contact with vaccine manufacturers, the acquisition of the vaccine and the policy for who receives it and in what sequence remains the exclusive responsibility of government, until such time as government informs otherwise,\u201d said Ryan Noach, CEO of the company\u2019s medical scheme Discovery Health.<\/p>\n

\u201cWe have been in regular liaison with vaccine manufacturers since September 2020,\u201d Noach said in an emailed response to Reuters. He said the company is taking all measures to \u201censure the procurement is efficient, and stock available quickly, especially for the most at risk.\u201d<\/p>\n

South Africa\u2019s vaccine rollout faced a blow in early February when it decided to halt the rollout of AstraZeneca\u2019s shots on concerns about its effectiveness against the 501Y.V2 variant that caused a huge spurt in infections late last year.<\/p>\n

The country has since opted for Johnson & Johnson\u2019s vaccine under an \u201cimplementation study.\u201d<\/p>\n

In a note to policyholders on Friday, Discovery\u2019s group CEO Adrian Gore said the company was aiming to vaccinate its three million adult policyholders, with the capacity of 50,000 vaccinations per day starting in May, if vaccine supplies are on time.<\/p>\n

\u201cThis will enable all of Discovery\u2019s 550,000 high-risk members to be vaccinated within a few weeks,\u201d he said.<\/p>\n

South Africa\u2019s Health Ministry did not immediately respond to Reuters request for comment when asked about private vaccine procurement.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

JOHANNESBURG (Reuters) – South African health insurer Discovery Ltd said on Monday it was in contact with all COVID-19 vaccine producers but cannot independently source […]<\/p>\n","protected":false},"author":3,"featured_media":110773,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nSouth African health insurer Discovery in touch with vaccine makers - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"South African health insurer Discovery in touch with vaccine makers - Fin2me\" \/>\n<meta property=\"og:description\" content=\"JOHANNESBURG (Reuters) – South African health insurer Discovery Ltd said on Monday it was in contact with all COVID-19 vaccine producers but cannot independently source [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-29T15:56:25+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/03\/cnewsfotor821.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/\",\"url\":\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/\",\"name\":\"South African health insurer Discovery in touch with vaccine makers - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-03-29T15:56:25+00:00\",\"dateModified\":\"2021-03-29T15:56:25+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"South African health insurer Discovery in touch with vaccine makers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"South African health insurer Discovery in touch with vaccine makers - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/","og_locale":"en_US","og_type":"article","og_title":"South African health insurer Discovery in touch with vaccine makers - Fin2me","og_description":"JOHANNESBURG (Reuters) – South African health insurer Discovery Ltd said on Monday it was in contact with all COVID-19 vaccine producers but cannot independently source [...]","og_url":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/","og_site_name":"Fin2me","article_published_time":"2021-03-29T15:56:25+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/03\/cnewsfotor821.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/","url":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/","name":"South African health insurer Discovery in touch with vaccine makers - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-03-29T15:56:25+00:00","dateModified":"2021-03-29T15:56:25+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/south-african-health-insurer-discovery-in-touch-with-vaccine-makers\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"South African health insurer Discovery in touch with vaccine makers"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/110774"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=110774"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/110774\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/110773"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=110774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=110774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=110774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}